Black Titan (NASDAQ:BTTC – Get Free Report) and Zenvia (NASDAQ:ZENV – Get Free Report) are both small-cap technology companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations and institutional ownership.
Institutional & Insider Ownership
49.2% of Zenvia shares are held by institutional investors. 0.7% of Black Titan shares are held by insiders. Comparatively, 78.4% of Zenvia shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares Black Titan and Zenvia’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Black Titan | N/A | N/A | N/A |
| Zenvia | -10.62% | -14.36% | -6.52% |
Valuation and Earnings
This table compares Black Titan and Zenvia”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Black Titan | $2.68 million | 1.20 | -$4.71 million | ($2.95) | -0.10 |
| Zenvia | $1.10 billion | 0.02 | -$28.67 million | ($0.40) | -1.17 |
Black Titan has higher earnings, but lower revenue than Zenvia. Zenvia is trading at a lower price-to-earnings ratio than Black Titan, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent ratings and recommmendations for Black Titan and Zenvia, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Black Titan | 1 | 0 | 0 | 0 | 1.00 |
| Zenvia | 1 | 0 | 0 | 0 | 1.00 |
Risk & Volatility
Black Titan has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500. Comparatively, Zenvia has a beta of 1.86, meaning that its share price is 86% more volatile than the S&P 500.
About Black Titan
Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.
About Zenvia
Zenvia Inc. is a Brazilian technology company that provides customer experience and communications solutions for businesses. Its platform is designed to help companies manage interactions with customers across multiple digital channels, supporting activities such as marketing, sales, customer service and engagement. The company’s products and services include application programming interfaces (APIs) and communications-platform-as-a-service tools for SMS, WhatsApp, voice and other messaging channels.
Receive News & Ratings for Black Titan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Black Titan and related companies with MarketBeat.com's FREE daily email newsletter.
